Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis

PHASE3CompletedINTERVENTIONAL

Enrollment

871

Participants

Timeline

Start Date

March 10, 2017

Primary Completion Date

November 15, 2017

Study Completion Date

March 27, 2018

Conditions

Bacterial Vaginosis

Interventions

DRUG

GDC-229

GDC-229 is a vaginal gel.

DRUG

Metronidazole Vaginal Gel 0.75%

Metronidazole Vaginal Gel 0.75% is an FDA-approved drug

DRUG

Placebo

Inactive arm of the study

Trial Locations (1)

Site 103, Raleigh